PINCR: A Non-Coding RNA Molecule Targeted by Small Molecule Inhibitors

Target Name: PINCR

NCBI ID: G101927501

PINCR

Other Name(s): P53-induced noncoding RNA | p53-induced noncoding RNA

PINCR: A Non-Coding RNA Molecule Targeted by Small Molecule Inhibitors

PINCR (P53-induced noncoding RNA) is a non-coding RNA molecule that is produced by the interaction of the tumor suppressor protein P53 and small non-coding RNAs (ncRNAs). P53 is a well-known protein that is often mutated in cancer and is involved in the regulation of cell growth, apoptosis, and DNA repair. The function of PINCR as a drug target or biomarker is of great interest due to its potential role in the development and progression of cancer.

PINCR: A novel drug target or biomarker

The identification of PINCR as a potential drug target or biomarker has significant implications for the development of new cancer therapies. PINCR has been shown to play a role in the regulation of cell growth, apoptosis, and DNA repair, making it an attractive target for small molecule inhibitors. Additionally, its expression has been shown to be downregulated in various types of cancer, which suggests that targeting PINCR may have the potential to be an effective cancer treatment.

PINCR functions as a negative regulator of P53

PINCR functions as a negative regulator of the tumor suppressor protein P53. P53 is a well-known protein that is involved in the regulation of cell growth, apoptosis, and DNA repair. Mutations in the P53 gene have been implicated in the development and progression of numerous types of cancer. The interaction between P53 and PINCR has been shown to play a role in the regulation of P53 activity.

PINCR is a non-coding RNA molecule produced by the interaction of P53 and small non-coding RNAs (ncRNAs). PINCR has been shown to play a negative role in the regulation of P53 activity by binding to P53 and inhibiting its activity. This interaction between PINCR and P53 has significant implications for the regulation of P53 activity and the development of cancer.

PINCR as a potential drug target

PINCR has been shown to be involved in the regulation of cell growth, apoptosis, and DNA repair, making it an attractive target for small molecule inhibitors. Small molecule inhibitors have the potential to be effective treatments for cancer because they can target specific mechanisms that are involved in cancer development and progression. Additionally, PINCR has been shown to be downregulated in various types of cancer, which suggests that targeting PINCR may have the potential to be an effective cancer treatment.

PINCR as a potential biomarker

PINCR has also been shown to be involved in the regulation of apoptosis, which is a critical mechanism that helps to remove damaged or dysfunctional cells from the body. The regulation of apoptosis is important for maintaining tissue homeostasis and has been implicated in the development and progression of various types of cancer.

In addition, the expression of PINCR has been shown to be downregulated in various types of cancer, which suggests that targeting PINCR may be an effective way to diagnose and monitor the effectiveness of cancer treatments. This is of great interest because it suggests that PINCR may be a useful biomarker for cancer diagnosis and treatment.

Conclusion

In conclusion, PINCR is a non-coding RNA molecule that is produced by the interaction of the tumor suppressor protein P53 and small non-coding RNAs. PINCR has been shown to play a role in the regulation of cell growth, apoptosis, and DNA repair, making it an attractive target for small molecule inhibitors. Additionally, its expression has been shown to be downregulated in various types of cancer, which suggests that targeting PINCR may have the potential to be an effective cancer treatment and a useful biomarker for cancer diagnosis and treatment. Further research is needed to fully understand the role of PINCR as a drug target and biomarker in the development and progression of cancer.

Protein Name: P53-induced Noncoding RNA

The "PINCR Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PINCR comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets